课题基金 / 基金详情

Regulation of autophagy and mitochondrial permeability by target of rapamycin complex 2

Regulation of autophagy and mitochondrial permeability by target of rapamycin complex 2
雷帕霉素复合物 2 靶标对自噬和线粒体通透性的调节
批准号:
10241881
负责人:
ALEXANDER A SOUKAS
金额:
$64.91万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-30 至 2022-08-31

项目摘要

项目成果

ALEXANDER A SOUKAS的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Autophagy is a conserved process by which all eukaryotic cells eliminate defective organelles and molecules, and is generally regarded as a health- and longevity-promoting process. Mutations in the autophagy machinery contribute to human conditions such as autoimmune, metabolic, inflammatory, neoplastic, and neurodegenerative diseases, and prompt changes consistent with premature aging. Conversely, nearly all genetic and environmental manipulations that extend lifespan do so in a manner dependent upon autophagy. However, we have determined that autophagy has negative consequences on health when it occurs in the setting of increased mitochondrial permeability. The net consequence of autophagy in the setting of increased mitochondrial permeability is shortened lifespan and increased susceptibility to ischemia/reperfusion injury. There is a critical need to understand the cellular and molecular mechanisms by which mitochondrial permeability is regulated in order to develop the next generation of interventions to reduce negative impacts of autophagy in aging and disease. The long-term goal of this project is to determine how mitochondrial permeability is regulated and to define the consequences of increased mitochondrial permeability on cellular and organismal dysfunction in aging. Our objective in this particular application is to define how upstream signaling pathways involved in promoting longevity and reducing disease suppress mitochondrial permeability, and the consequences this has on autophagy, mitochondrial function, and lifespan. This project will meet this objective by studying the detailed mechanisms by which mitochondrial permeability is regulated and the consequences of this regulation. We have determined that defects in signaling in the mTOR complex 2 pathway lead to increases in mitochondrial permeability and autophagy, shortening lifespan and increasing ischemia/reperfusion injury. The central hypothesis of this proposal is that low mitochondrial permeability is a central determinant of the effects of autophagy on lifespan and aging-associated diseases. The rationale for this proposal is that fuller understanding of the regulation of mitochondrial permeability will permit us to target permeability to promote healthy aging in humans. Guided by preliminary data, we will test our hypothesis in three specific aims. In Aim 1, we will define the mechanisms by which mitochondrial permeability is decreased by prolongevity pathways. In Aim 2 we will define the mechanisms by which mitochondrial permeability and defects in mTOR complex 2 signaling drive autophagy. Aim 3 will determine the mechanism by which the union of mitochondrial permeability and autophagy shorten lifespan. At the conclusion of these studies, we will have identified the major mechanisms by which mitochondrial permeability disrupts cellular function and shortens lifespan. The proposed research is significant because it will have broad implications for rational design of the next generation of interventions that promote healthy aging through manipulation of autophagy and mitochondrial permeability.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Boston Area Diabetes and Endocrinology Research Center (BADERC)
  • 批准号:
    10586200
  • 项目类别:
  • 资助金额:
    $109.07万
  • 财政年份:
    2023
  • 负责人:
    ALEXANDER A SOUKAS
  • 依托单位:
Admin Core
  • 批准号:
    10586201
  • 项目类别:
  • 资助金额:
    $35.6万
  • 财政年份:
    2023
  • 负责人:
    ALEXANDER A SOUKAS
  • 依托单位:
Autophagy and Mitochondrial Permeability in Aging and Longevity
  • 批准号:
    10688322
  • 项目类别:
  • 资助金额:
    $34.44万
  • 财政年份:
    2022
  • 负责人:
    ALEXANDER A SOUKAS
  • 依托单位:
Mitochondrial action of metformin in aging and longevity
  • 批准号:
    10087180
  • 项目类别:
  • 资助金额:
    $42.0万
  • 财政年份:
    2020
  • 负责人:
    ALEXANDER A SOUKAS
  • 依托单位: